Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Perspective Volume 3 Issue 12

Covid Associated Mucormycosis in India

Rashmi Kaul Raina*

Department of Pathology, Dr Rajendra Prasad Government Medical College, Kangra at Tanda (H.P), India

*Corresponding Author: Rashmi Kaul Raina, Department of Pathology, Dr Rajendra Prasad Government Medical College, Kangra at Tanda (H.P), India.

Received: October 26, 2021; Published: November 19, 2021

Mucormycosis or ‘Black Fungus’ is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. The spores of this fungus are ubiquitous in the atmosphere. Healthy individuals continue to breathe in the air without getting affected. During the second phase of COVID pandemic, the word ‘black fungus’ became a dreaded household term in India.

Over the last three decades the incident cases of mucormycosis have shown a rising trend in India, but the exponential growth of cases during the second wave of covid pandemic was unprecedented.

Before the covid-19 pandemic, mucormycosis was 80 times more prevalent in India than in developed countries [1]. Mucormycosis was declared a notifiable disease in India in May, 2021 following the surge in cases.

References

  1. https://www.who.int/india/emergencies/coronavirus-disease-(covid-19)/mucormycosis
  2. Prakash H and Chakrabarti A. “Epidemiology of Mucormycosis in India”. Microorganisms 9 (2021): 523.
  3. Walsh TJ., et al. “Development of new strategies for early diagnosis of mucormycosis from bench to bedside”. Mycoses 57 (2014): 2-7.
  4. Cornely OA., et al. “Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium”. Lancet Infectious Disease 19 (2019): e405-e421.

Citation

Citation: Rashmi Kaul Raina. “Covid Associated Mucormycosis in India".Acta Scientific Otolaryngology 3.12 (2021): 15-16.

Copyright

Copyright: © 2021 Rashmi Kaul Raina. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In







News and Events


Contact US